Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Non-Current Liabilities: 2015-2020

Historic Other Non-Current Liabilities for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $181,098.

  • Outlook Therapeutics' Other Non-Current Liabilities fell 95.45% to $181,098 in Q2 2020 from the same period last year, while for Jun 2020 it was $181,098, marking a year-over-year decrease of 95.45%. This contributed to the annual value of $3.9 million for FY2019, which is 12.18% up from last year.
  • Per Outlook Therapeutics' latest filing, its Other Non-Current Liabilities stood at $181,098 for Q2 2020, which was up 237.92% from $53,592 recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Other Non-Current Liabilities ranged from a high of $4.1 million in Q4 2016 and a low of $53,592 during Q1 2020.
  • In the last 3 years, Outlook Therapeutics' Other Non-Current Liabilities had a median value of $3.3 million in 2018 and averaged $2.7 million.
  • In the last 5 years, Outlook Therapeutics' Other Non-Current Liabilities skyrocketed by 754.93% in 2016 and then slumped by 98.37% in 2020.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Other Non-Current Liabilities stood at $4.1 million in 2016, then tumbled by 38.02% to $2.6 million in 2017, then soared by 32.77% to $3.4 million in 2018, then grew by 15.49% to $3.9 million in 2019, then plummeted by 95.45% to $181,098 in 2020.
  • Its Other Non-Current Liabilities stands at $181,098 for Q2 2020, versus $53,592 for Q1 2020 and $3.9 million for Q4 2019.